Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Dalian Medical UniversityActive in the last 2 years

Zhizhou Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1928-7940; OpenAlex author ID A5078704949. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Integrated Multiomics Unravels Hedgehog (HH) Signaling Characteristics in Pancreatic Cancer (PC) and DCBLD2 Regulates HH Signaling to Drive PC Progression. Last author DOI 10.1155/humu/4806397↗
  2. A stumbling block in pancreatic cancer treatment: drug resistance signaling networks. Co-author DOI 10.3389/fcell.2024.1462808↗
  3. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Net… Co-author DOI 10.3389/fgene.2021.692953↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Shang · 2 shared papers, 2021–2024 · strength 0.40
  2. Biao Zhang · 1 shared paper, 2025 · strength 0.28
  3. Biao Zhang · 1 shared paper, 2024 · strength 0.24
  4. Jinming Liu · 1 shared paper, 2024 · strength 0.24
  5. Qihang Yuan · 1 shared paper, 2021 · strength 0.16
  6. Dawei Deng · 1 shared paper, 2021 · strength 0.16
  7. Ji Li · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.